Cullinan Therapeutics, Inc.
USD17.69
+1.28 (+7.80%)
CEO
Nadim Ahmed
IPO Date
2021-01-08
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
NASDAQ
Country
US
Open
$16.13
Prev. Close
$16.41
Day Low
$16.00
Day High
$17.89
52W Low
$5.68
52W High
$19.43
Market Cap
$1.09B
Volume
0.58M
| 8,000 |
| $17.82 |
| 7 Jul 2026 | Michaelson Jennifer | Chief Scientific Officer | M-Exempt | Disposed | 4,000 | $4.30 |
| 2 Jul 2026 | SUMER JACQUELYN L | Chief Legal Officer | A-Award | Acquired | 2,470 | $8.60 |
| 2 Jul 2026 | Fenton Mary Kay | Chief Financial Officer | A-Award | Acquired | 1,541 | $8.60 |
| 18 Jun 2026 | Rosenberg Anthony | director | A-Award | Acquired | 25,319 | $13.55 |
| 18 Jun 2026 | Meek David D. | director | A-Award | Acquired | 25,319 | $13.55 |
| 18 Jun 2026 | Webster Stephen W | director | A-Award | Acquired | 25,319 | $13.55 |
| 18 Jun 2026 | Allen Andrew R | director | A-Award | Acquired | 21,781 | $13.55 |
| 18 Jun 2026 | Thistle Mary | director | A-Award | Acquired | 25,319 | $13.55 |